Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Radiotherapiegroep in the Netherlands to acquire Elekta Unity and Versa HD cancer treatment systems

STOCKHOLM, April 27, 2019 – Elekta (EKTA-B.ST) announced today that Radiotherapiegroep Arnhem/Deventer in the Netherlands has ordered an Elekta Unity MR-linac as well as five Versa HD™ linear accelerators. Elekta Unity combines two technologies – a state-of-the-art 1.5T MRI scanner and a best-in-class 7MV linear accelerator. It is transforming cancer care with the potential to preserve more healthy tissue than ever before, enabling the use of radiation therapy in hard-to-treat cancers, and going beyond anatomy with biological MRI to assess tumor responses early in treatment. Karin

XVIVO has received market approval (PMA) from the FDA for STEEN Solution™ and XPS™

On April 26, 2019 XVIVO received Premarket approval (PMA) from the FDA for the products XPS™ and STEEN Solution™ for sale on the American market. The approval means that STEEN Solution™, XPS™ and the accompanying single-use articles are the only medical device products that are approved for Ex Vivo Lung Perfusion (EVLP) of initially unacceptable donated lungs at body temperature.Please see FDA press release on the following link: https://www.fda.gov/news-events/press-announcements/fda-approves-device-help-increase-access-more-lungs-transplant Just over 40 percent of all lung

Filo Mining Announces New Supplemental Credit Facility

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, April 26, 2019 /CNW/ - Filo Mining Corp. (TSX-V, Nasdaq First North: FIL) ("Filo Mining”, or the “Company”) is pleased to announce that it has entered into a new US$4,000,000 credit facility (the "New Facility"), which will be evidenced by a debenture (the "New Debenture"), to provide additional financial flexibility to fund the Company’s ongoing work programs and provide general working capital. The New Facility has a term of 12 months ending April 26, 2020 (the "Maturity Date").

Sinch has published its Annual Report for 2018

Stockholm, Sweden - CLX Communications AB (publ) - XSTO: SINCH Sinch, a global leader in cloud communications for mobile customer engagement, today announced it has published its Annual Report for 2018. The report is available for download at investors.sinch.com . For further information, please contact Thomas HeathChief Strategy Officer and Head of Investor RelationsCLX Communications AB (publ)Mobile:       +46-722-45 50 55E-mail:       thomas.heath@sinch.com About Sinch (CLX Communications AB) Sinch brings

Golden Heights Aktiebolag (publ) publishes notes prospectus and applies for listing of its notes on Nasdaq Stockholm

NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN USA, AUSTRALIA, CANADA, HONG KONG, JAPAN OR SOUTH AFRICA. On 8 March 2019, Golden Heights AB (publ) (”Golden Heights”) issued SEK 400 million of three year floating rate Notes. In accordance with the Terms and Conditions of the Notes, Golden Heights has applied for listing of the Notes on Nasdaq Stockholm’s corporate bond list and prepared a prospectus for the listing. The prospectus was approved by the Swedish Financial Supervisory Authority on 26th April 2019. The Notes are expected to be listed for trading on or around

Result of AGM

26 April 2019 17:45 BST Results of Annual General Meeting held on 26 April 2019 AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 1 – 8 were passed as ordinary resolutions and resolutions 9 – 12 were passed as special resolutions. +--+----------------------+--------------+-----+-----------+-----+-------------+-------+----------+| |RESOLUTION |VOTES FOR |% OF |VOTES |% OF |VOTES CAST IN|TOTAL |VOTES || |

Intrum’s Annual General Meeting 2019

Dividend The annual general meeting adopted the board’s proposal for a dividend of SEK 9.50 per share. The record day for the dividend is Tuesday, 30 April 2019. The dividend is expected to be distributed by Euroclear Sweden AB on Monday, 6 May 2019.Board and board remuneration   The annual general meeting re-elected Per E. Larsson, Hans Larsson, Kristoffer Melinder, Andreas Näsvik, Ragnhild Wiborg, Magdalena Persson and Magnus Yngen as board members. Liv Fiksdahl and Andrés Rubio were elected as new board members. The annual general meeting re-elected Per E. Larsson as chairman

Issues of shares following the vesting of 2016/2019 incentive plan

Uppsala, Sweden - April 26, 2019 – The 2016 annual general meeting of Orexo resolved on a long-term incentive plan for senior executives and key employees within the Orexo group (“LTIP 2016/2019”). Participants in LTIP 2016/2019 were granted share awards, entitling to shares in the company, subject to certain performance conditions, after a three-year vesting period. Given the company’s positive development since 2016, the performance conditions under LTIP 2016/2019 have been satisfied and participants in the plan, including members of Orexo’s group management, will be eligible to receive

Immunovia - Report from AGM

The Annual General Meeting (AGM) of Immunovia AB (publ), corporate identity number 556730-4299 was held at Gamla Gästmatsalen in Medicon Village, Scheelevägen 2, Lund, Sweden on April 26 2019. A summary of the Meeting’s resolutions follows: Appropriation of the company’s profit and loss The Meeting resolved that the funds at its disposal of SEK 442,629,518 should be carried forward. Directors’ and audit fees The Meeting resolved that Board members should be compensated with SEK 150,000 for Directors and SEK 400,000 for the Chairman of the Board. The Chairman of the Audit

Bambuser publishes outcomes in the rights issue

On April 24, 2019, the subscription period for the rights issue in Bambuser AB was terminated. The issue amounting to approximately SEK 13 million has been fully subscribed.The final calculation of the outcome shows that 6 501 912 shares, corresponding to 28,6 percent, were subscribed with the support of subscription rights and  161 340 shares, corresponding to 0,7 percent, were subscribed without the support of subscription rights. Remaining 16 098 995  shares, corresponding to 70,7 percent of the issue, are subscribed for by the underwriters. The rights issue is thus subscribed to 100

interim report 2019, January to March

profit before tax EUR 197 millionRental income was EUR 129 million,an increase of 2.8 percent for comparable properties.  Operating surplus was EUR 65 million,up by 0.2 percent for comparable properties.   The increase in property value was EUR 192 million,equivalent to 1.5 percent.   At the end of March, the market value of the property portfolio was EUR 12,830 million.  Binding agreement signed during the quarter for the disposal of Akelius’ properties in Cologne, Dusseldorf, Frankfurt, Wiesbaden and Mainz.Price EUR 685 million.Closing during summer 2019.  The

HIDDN - Update to the financial calendar – postponed timing for Annual General Meeting

Reference is made to the announcement made by Hiddn Solutions ASA (the “Company”) on 25 March 2019 regarding a potential business combination with Energos Group AS. The completion of the transaction is subject to amongst others, due diligence, final transaction agreements and approval by the shareholders in the Company. The transaction is expected to close during the second quarter of 2019. The Annual General Meeting in Hiddn Solutions ASA, scheduled for 15 May 2019 has been postponed to be aligned with the process following the proposed business combination with Energos Group AS and

Annual general meeting of HEXPOL AB

At today’s Annual General Meeting of HEXPOL AB (publ), the following was resolved. Board of Directors, auditor and fees The number of directors will be seven. The meeting re-elected Georg Brunstam, Alf Göransson, Jan- Anders Månson, Malin Persson, Kerstin Lindell, Märta Schörling Andreen and Gun Nilsson. Georg Brunstam was elected Chairman of the Board. The fees to the Board of Directors shall amount to a total of SEK 3,890,000 (including fees for committee work). Re-election of the accounting firm Ernst & Young AB, for a period of mandate of one year, consequently up to and

Share buy-back by Zalaris ASA

On 26 April 2019, Zalaris ASA purchased 2053 own shares on the Oslo Stock Exchange at an average price of NOK 25,2918. Following the purchase Zalaris ASA holds 238.793 own shares, representing ~1,19% of the total outstanding shares. The shares were purchased in accordance with the share buy-back programme announced 12 March 2019, available at www.newsweb.no. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

#19-884 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

NCC’s Board of Directors has decided to purchase own Series B shares

Pursuant to its mandate from the Annual General Meeting held on April 9, 2019, the Board of Directors of NCC AB (publ) has decided to purchase own Series B shares.The reason for the Board of Directors’ decision to utilize the mandate concerning the purchase of own shares is to secure the company’s obligations relating to delivery and to cover costs for tax and social security fees due to NCC’s outstanding long-term performance-based incentive program LTI 2019. The repurchases are subject to the following terms and conditions.  · Acquisitions may be conducted on one or more occasions

Read original

Aker ASA: AKER ENERGY COMPLETES APPRAISAL DRILLING CAMPAIGN OFFSHORE GHANA, CONTINUES WORK ON PDO

Aker Energy Ghana Ltd. (“Aker Energy”, “the Company”), as the operator of the Deepwater Tano Cape Three Points (DWT/CTP) block, announces that is has concluded its appraisal drilling campaign offshore Ghana. The Company is currently working on a revised Plan for Development and Operations (PDO), following scheduled feedback from Ghanaian authorities.“Based on close collaboration with Ghanaian authorities, regulators and our license partners, Aker Energy submitted an application for approval of a comprehensive development plan with the objective of maximising oil recovery in the DWT/CTP area

Notice of Annual General Meeting in Cantargia AB (publ)

The shareholders of Cantargia AB (publ) are invited to the Annual General Meeting on Monday, 27 May 2019, at 4 p.m. CET at Medicon Village, Scheelevägen 2, Lund, Sweden.Right to participate and noticeShareholders who wish to participate in the meeting must: · be recorded in the share register maintained by Euroclear Sweden AB on Tuesday, 21 May 2019, and · notify the company of their intention to participate in the Meeting not later than Tuesday, 21 May 2019. The notice shall be made by mail to Cantargia AB (publ), Medicon Village, Scheelevägen 2, SE-223 81 Lund, Sweden. Notice

Elekta files patent infringement lawsuit against ZAP Surgical Systems Inc.

SUNNYVALE, USA, April 26, 2019 – Elekta (EKTA-B.ST), a pioneer in development of precision radiation therapy, radiosurgery and clinical software for the treatment of cancer and neurological disorders, announced today it has filed a patent infringement lawsuit against ZAP Surgical Systems Inc. in the United States District Court for the Northern District of California. The lawsuit was filed by Elekta Limited and Elekta Inc. and asserts that the manufacture, importation, advertising, sale, and use of the ZAP-X® Gyroscopic Radiosurgery™ Platform infringes U.S. Patent No. 7,295,648 on Elekta’

Bulletin from the Annual General Meeting of Formpipe Software AB held 26 April 2019

Allocation of the company’s results and discharge from liabilityThe Annual General Meeting (AGM) resolved in accordance with the Board of Directors’ proposal that SEK 0.60 per share shall be paid in dividend to the shareholders for the financial year 2018, and that the record date for the dividend shall be 30 April 2019. The dividend is expected to be distributed by Euroclear Sweden AB on 6 May 2019. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2018. Election of Directors, Chairman of the Board, auditor, fees, and principles

Correction to Atria Plc's company announcement on 26 April 2019 at 15.00 pm: Decisions of Atria Plc's Annual General Meeting

Atria Plc   Company Announcement, 26 April 2019 at 16.55 pm Correction to Atria Plc's company announcement on 26 April 2019 at 15.00 pm:Decisions of Atria Plc's Annual General Meeting In the English company announcement Decisions of Atria Plc's Annual General Meeting there is an error in chapter " Dividend of EUR 0.40 per share". Corrected chapter: Dividend of EUR 0.40 per shareThe General Meeting resolved that a dividend of EUR 0.40 per share be distributed for the financial period which ended on 31 December 2018. Dividend is paid to a shareholder entered in the Company's

There are no items matching the current filter
There are no more items matching the current filter
Back to top